// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Late Breaking Abstract - European prevalence of OSA in adults: Estimation using currently available data

Atul Malhotra - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Reducing plastic waste, carbon footprint and cost: inhaler recycling at Musgrove Park Hospital

Alexandra Dipper - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

High flow nasal cannula in patients not suitable for invasive ventilation – are we missing an opportunity for palliative care?

Hazel Morrison - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Biodiesel: is it any safer to use?

James A. Bolaji - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cysteine Hydrochloride

Identifying Asthmatic Children using Tidal Breathing Parameters Measured by Structured Light Plethysmography (SLP)

Hamzah Hmeidi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Investigating the feasibility of a mobile mindfulness-based digital intervention for patients with asthma

Ben Ainsworth - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anxiety

N/A

In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease

SV Ruickbie - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Short Physical Performance Battery and long term prognosis following severe acute exacerbation of COPD: a prospective cohort study

Ruth Barker - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Novel cell types and altered cell states in asthma revealed by single-cell RNA sequencing of airway wall biopsies.

Martijn Nawijn - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Muscle hypertrophy

N/A

The effect of inhaler switching on asthma and COPD patients

Chloe Bloom - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases

Gareth Walters - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Extrinsic allergic alveolitis

N/A

Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review

Conal Hayton - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Change of inhaled medications during hospital admissions for acute exacerbation of COPD

Victoria Ridley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Variability in access and referral to pulmonary rehabilitation in European bronchiectasis patients enrolled in the EMBARC registry

Paul Walker - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms

Kay Wang - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Asthma

N/A

Impact of doxofylline in COPD: a pair-wise meta-analysis

Mario Cazzola - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Doxofylline

Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases

Athina Trachalaki - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Patient views on payment for trial participation

Rebecca Dobra - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Ventilatory efficiency during exercise: data from a contemporary cohort of preterm-born children

John Lowe - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure

David Price - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

N/A

Copyright © 2026. QuantiNova All rights reserved